Sort
64,565 grants matching “drug discovery”
Abdominal Symptom Phenotypes: Pathways to New Biomarkers
$995,519Margaret McLean Heitkemper · University Of Washington · RC2 · FY2009 · NR
Novel Therapeutic Strategies Targeting Re-emerging Alphaviruses
$995,510Daniel N Streblow · University Of Alabama At Birmingham · U19 · FY2015 · AI
Research and Development to Establish a Small Animal Model as a Significant Resource of High-Value Single-Domain Antibodies
$995,450Milen Kirilov · Ingenious Targeting Laboratory, Inc. · R44 · FY2023 · AI
Gulf Coast Consortia (GCC) Research Evaluation and Commercialization Hub
$995,246Peter J Davies · Texas A&M University Health Science Ctr · U01 · FY2024 · GM
PIXUL-FFPE: High throughput platform for chromatin and DNA sample preparation from formalin fixed paraffin embedded (FFPE) tissue samples.
$995,238Karol Bomsztyk · Matchstick Technologies, Inc. · R42 · FY2020 · HG
A phenotypic screen for compounds that differentially affect excitatory and inhibitory neuronal signaling
$995,203Steven John Ryan · Quiver Bioscience Inc. · R44 · FY2022 · MH
Discovery of Critical Host Genes Enabling Resistance to HIV-1 Infection as Therap
$995,189Leyla S Diaz · Functional Genetics, Inc. · R44 · FY2011 · AI
Advancing a novel potent Zika virus specific nucleoside analog to the clinic
$995,099Klaus Klumpp · Riboscience, Llc · R44 · FY2018 · AI
Advancing a novel potent Zika virus specific nucleoside analog to the clinic
$995,099Klaus Klumpp · Riboscience, Llc · R44 · FY2019 · AI
Center for Interventional Oncology
$995,007Bradford J Wood · Division Of Basic Sciences - Nci · ZID · FY2010 · CA
Heterocyclic Inhibitors of QcrB as Novel Drugs for Tuberculosis
$994,977Thomas Joseph Hannan · Fimbrion Therapeutics, Inc. · R44 · FY2024 · AI
NeuroExM
$994,964Jacob R Glaser · Microbrightfield, Llc · R42 · FY2022 · MH
Animal Efficacy and Pharmacometric Modeling Core
$994,870Isabel Lauren Jackson · University Of Maryland Baltimore · U19 · FY2021 · AI
Vanderbilt Genome Electronic Records Project
$994,819Dan M Roden · Vanderbilt University · U01 · FY2014 · HG
Providing GMP-grade Terbium-161 as a therapeutic option for US academic institution
$994,810Ian Horvath · Fusion Energy Solutions, Inc. D/B/A Serva Energy · R44 · FY2025 · CA
Next-generation 5-nitroimidazoles against giardiasis
$994,801Lars Eckmann · University Of California, San Diego · U01 · FY2007 · AI
Midwest Biomedical Accelerator Consortium: MBArC
$994,707William P Fay · University Of Missouri-Columbia · U01 · FY2019 · HL
NeuroExM
$994,696Jacob R Glaser · Microbrightfield, Llc · R42 · FY2024 · MH
3D Bioprinted skin models for drug screening
$994,550Marc Ferrer · National Center For Advancing Translational Sciences · ZIA · FY2024 · TR
3D Bioprinted lung cancer models for drug screening
$994,549Marc Ferrer · National Center For Advancing Translational Sciences · ZIA · FY2024 · TR
Washington Entrepreneurial Research Evaluation and Commercialization Hub
$994,469Rodney J.y. Ho · University Of Washington · U01 · FY2020 · HL
Washington Entrepreneurial Research Evaluation and Commercialization Hub
$994,469Rodney J.y. Ho · University Of Washington · U01 · FY2021 · HL
Washington Entrepreneurial Research Evaluation and Commercialization Hub
$994,469Rodney J.y. Ho · University Of Washington · U01 · FY2022 · HL
Drug Repurposing Screening for Zika Virus Infection
$994,436Wei Zheng · National Center For Advancing Translational Sciences · ZIA · FY2016 · TR
III: Medium: Algorithms and Software Tools for Epigenetics Research
$994,370Stefano Lonardi · University Of California-Riverside · · FY2013 · CSE